期刊
JOURNAL OF CANCER
卷 9, 期 17, 页码 3067-3077出版社
IVYSPRING INT PUBL
DOI: 10.7150/jca.26382
关键词
osteosarcoma; tumor suppressor; metastasis; NKX2-2; transcription factor
类别
资金
- Science and Technology Program of Guangzhou, China [201508020102]
- National Key Research and Development Program of China [2016YFC0904601, 2016YFA0500304]
- National Nature Science Foundation of China (NSFC) [81772922, 81502512, 81530081, 31571395]
- Guangdong Natural Science Foundation Team Project [2014A030312015]
- Special Key Project of Guangzhou Scientific Research [201607020038]
- Natural Science Foundation of Guangdong Province [2016A030310218]
- Fundamental Research Funds for the Central Universities [16ykpy39]
Osteosarcoma is the most common primary malignant bone tumor. However, our understanding of the molecular mechanism underlying its pathogenesis is incomplete. Studies have shown that aberrant expression of NK homeobox (NKX) genes may be involved in the oncogenesis of various cancers. Here, through migration screening assay, we found that a series of NKX genes inhibit the migration of osteosarcoma cells. Among these genes, NKX2-2 is a bona fide tumor suppressor for osteosarcoma. Overexpression of NKX2-2 decreases the migration, invasion, proliferation and colony formation of osteosarcoma cells in vitro and suppresses tumor growth and metastasis in vivo. Moreover, based on the results from both in vitro and in vivo studies, the transcriptional activation domain of NKX2-2 is important for its tumor suppressor function. Mechanistically, we revealed that NKX2-2 acts as a tumor suppressor partially by mediating the transcriptional downregulation of COL5A2, PLAU, SEMA7A and S1PR1 genes. In summary, our studies of NKX2-2 revealed new molecular mechanisms underlying osteosarcoma proliferation and metastasis and may provide a series of potential therapeutic targets for osteosarcoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据